NIH Grant Fuels Catalight's Behavioral Intervention Program Expansion

Event summary

  • Catalight received a $4.5 million NIH R01 grant to study RUBIES, a program for educators supporting autistic elementary students.
  • The study, commencing in 2026, will be a five-year randomized trial across multiple schools nationwide.
  • The research will evaluate RUBIES alongside a new school leadership support strategy called HELM.
  • RUBIES is an adaptation of RUBI, a program previously validated through three NIH-funded trials.
  • Karen Bearss, Ph.D., Vice President of Caregiver-Mediated Solutions at Catalight, is leading the research.

The big picture

The grant highlights the growing recognition of the need for specialized training and support for educators working with autistic students, a population often underserved within public school systems. Catalight’s position as a large behavioral health network ($16,000 practitioners, 24,000 clients annually) gives it significant reach to implement and study interventions at scale, but also increases scrutiny of its program's effectiveness. The inclusion of a leadership support component (HELM) signals a shift towards addressing systemic barriers to program adoption, a critical factor for long-term impact.

What we're watching

Implementation Risk
The success of RUBIES hinges on the adoption and sustained use of the program by educators, which will depend on the effectiveness of the HELM leadership support strategy.
Clinical Validation
The five-year trial's results will be crucial in determining the long-term efficacy of RUBIES and its potential for widespread adoption in public schools.
Scalability
The nationwide rollout will test Catalight’s ability to manage a large-scale research study and potentially expand its behavioral health network’s reach.